Skip to content
PubMed This is a summary of 56 peer-reviewed journal articles Updated

Research & Literature

Explore the leading researchers and institutions driving advances in this area, and dive into the full body of literature that informs this resource.

Explore the Literature Visualize citation networks across 56 referenced papers

Top Authors

Carlo Nobile
University of Padua
Emanuela Dazzo
University of Padua
Roberto Michelucci
Istituto delle Scienze Neurologiche di Bologna
Pasquale Striano
Istituto Giannina Gaslini
Francesca Bisulli
Istituto delle Scienze Neurologiche di Bologna
Jacqueline A. French
New York University
Paolo Tinuper
Istituto delle Scienze Neurologiche di Bologna
Laura Licchetta
Istituto delle Scienze Neurologiche di Bologna
Salvatore Striano
Federico II University Hospital
Tommaso Pippucci
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola

Top Institutions

Ranked by publications Top 10 institutions
07

International League Against Epilepsy

West Hartford, United States

12 papers
08

Federico II University Hospital

Naples, Italy

9 papers

References

References (56)
  1. 1

    Heterozygous reelin mutations cause autosomal-dominant lateral temporal epilepsy.

    Dazzo E, Fanciulli M, Serioli E, et al.

    American journal of human genetics 2015; (96(6)):992-1000.

    PMID: 26046367
  2. 2

    Autosomal dominant epilepsy with auditory features: a new LGI1 family including a phenocopy with cortical dysplasia.

    Klein KM, Pendziwiat M, Cohen R, et al.

    Journal of neurology 2016; (263(1)):11-6 doi:10.1007/s00415-015-7921-2.

    PMID: 26459092
  3. 3

    Screening LGI1 in a cohort of 26 lateral temporal lobe epilepsy patients with auditory aura from Turkey detects a novel de novo mutation.

    Kesim YF, Uzun GA, Yucesan E, et al.

    Epilepsy research 2016; (120()):73-8.

    PMID: 26773249
  4. 4

    Genetics of reflex seizures and epilepsies in humans and animals.

    Italiano D, Striano P, Russo E, et al.

    Epilepsy research 2016; (121()):47-54.

    PMID: 26875109
  5. 5

    Small temporal pole encephalocele: A hidden cause of "normal" MRI temporal lobe epilepsy.

    Toledano R, Jiménez-Huete A, Campo P, et al.

    Epilepsia 2016; (57(5)):841-51 doi:10.1111/epi.13371.

    PMID: 27020612
  6. 6

    Treatment of Established Status Epilepticus.

    Falco-Walter JJ, Bleck T

    Journal of clinical medicine 2016; (5(5)).

    PMID: 27120626
  7. 7

    Clinical analysis of leucine-rich glioma inactivated-1 protein antibody associated with limbic encephalitis onset with seizures.

    Li Z, Cui T, Shi W, Wang Q

    Medicine 2016; (95(28)):e4244 doi:10.1097/MD.0000000000004244.

    PMID: 27428233
  8. 8

    Secretion-Positive LGI1 Mutations Linked to Lateral Temporal Epilepsy Impair Binding to ADAM22 and ADAM23 Receptors.

    Dazzo E, Leonardi E, Belluzzi E, et al.

    PLoS genetics 2016; (12(10)):e1006376 doi:10.1371/journal.pgen.1006376.

    PMID: 27760137
  9. 9

    The clinical phenotype of autosomal dominant lateral temporal lobe epilepsy related to reelin mutations.

    Michelucci R, Pulitano P, Di Bonaventura C, et al.

    Epilepsy & behavior : E&B 2017; (68()):103-107 doi:10.1016/j.yebeh.2016.12.003.

    PMID: 28142128
  10. 10

    Instruction manual for the ILAE 2017 operational classification of seizure types.

    Fisher RS, Cross JH, D'Souza C, et al.

    Epilepsia 2017; (58(4)):531-542 doi:10.1111/epi.13671.

    PMID: 28276064
  11. 11

    Practice Guideline Summary: Sudden Unexpected Death in Epilepsy Incidence Rates and Risk Factors: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

    Harden C, Tomson T, Gloss D, et al.

    Epilepsy currents 2017; (17(3)):180-187 doi:10.5698/1535-7511.17.3.180.

    PMID: 28684957
  12. 12

    CNTNAP2 mutations and autosomal dominant epilepsy with auditory features.

    Leonardi E, Dazzo E, Aspromonte MC, et al.

    Epilepsy research 2018; (139()):51-53 doi:10.1016/j.eplepsyres.2017.11.006.

    PMID: 29179159
  13. 13

    The current place of epilepsy surgery.

    Engel J

    Current opinion in neurology 2018; (31(2)):192-197 doi:10.1097/WCO.0000000000000528.

    PMID: 29278548
  14. 14

    Mutations in MICAL-1cause autosomal-dominant lateral temporal epilepsy.

    Dazzo E, Rehberg K, Michelucci R, et al.

    Annals of neurology 2018; (83(3)):483-493 doi:10.1002/ana.25167.

    PMID: 29394500
  15. 15

    Epilepsy with auditory features: Long-term outcome and predictors of terminal remission.

    Bisulli F, Menghi V, Vignatelli L, et al.

    Epilepsia 2018; (59(4)):834-843 doi:10.1111/epi.14033.

    PMID: 29464704
  16. 16

    Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new-onset epilepsy: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology and the American Epilepsy Society.

    Kanner AM, Ashman E, Gloss D, et al.

    Neurology 2018; (91(2)):74-81 doi:10.1212/WNL.0000000000005755.

    PMID: 29898971
  17. 17

    The landscape of epilepsy-related GATOR1 variants.

    Baldassari S, Picard F, Verbeek NE, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2019; (21(2)):398-408 doi:10.1038/s41436-018-0060-2.

    PMID: 30093711
  18. 18

    Practice guideline update summary: Efficacy and tolerability of the new antiepileptic drugs II: Treatment-resistant epilepsy: Report of the American Epilepsy Society and the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology.

    Kanner AM, Ashman E, Gloss D, et al.

    Epilepsy currents 2018; (18(4)):269-278 doi:10.5698/1535-7597.18.4.269.

    PMID: 30254528
  19. 19

    SYNGAP1 encephalopathy: A distinctive generalized developmental and epileptic encephalopathy.

    Vlaskamp DRM, Shaw BJ, Burgess R, et al.

    Neurology 2019; (92(2)):e96-e107 doi:10.1212/WNL.0000000000006729.

    PMID: 30541864
  20. 20

    Factors predicting uncontrolled seizures in epilepsy with auditory features.

    Zhang L, Zhu X, Zou X, Chen L

    Seizure 2019; (65()):55-61 doi:10.1016/j.seizure.2018.12.023.

    PMID: 30612076
  21. 21

    Autosomal dominant temporal lobe epilepsy associated with heterozygous reelin mutation: 3 T brain MRI study with advanced neuroimaging methods.

    Česká K, Aulická Š, Horák O, et al.

    Epilepsy & behavior case reports 2019; (11()):39-42 doi:10.1016/j.ebcr.2018.10.003.

    PMID: 30619712
  22. 22

    Risk Factors for Sudden Unexpected Death in Epilepsy (SUDEP) and Their Mitigation.

    Whitney R, Donner EJ

    Current treatment options in neurology 2019; (21(2)):7 doi:10.1007/s11940-019-0547-4.

    PMID: 30758730
  23. 23

    Prognostic factors of postoperative seizure outcome in patients with temporal lobe epilepsy and normal magnetic resonance imaging.

    Mariani V, Revay M, D'Orio P, et al.

    Journal of neurology 2019; (266(9)):2144-2156 doi:10.1007/s00415-019-09394-x.

    PMID: 31127383
  24. 24

    Clinical risk factors in SUDEP: A nationwide population-based case-control study.

    Sveinsson O, Andersson T, Mattsson P, et al.

    Neurology 2020; (94(4)):e419-e429 doi:10.1212/WNL.0000000000008741.

    PMID: 31831600
  25. 25

    Predictors of drug-resistance in epilepsy with auditory features.

    Zhang L, Zhu X, Peng A, et al.

    Epilepsy research 2020; (164()):106353 doi:10.1016/j.eplepsyres.2020.106353.

    PMID: 32447239
  26. 26

    Autosomal dominant lateral temporal lobe epilepsy associated with a novel reelin mutation.

    Michelucci R, Dazzo E, Volpi L, et al.

    Epileptic disorders : international epilepsy journal with videotape 2020; (22(4)):443-448 doi:10.1684/epd.2020.1176.

    PMID: 32723706
  27. 27

    Diagnostic yield of seizure recordings and neuroimaging in patients with focal epilepsy without interictal epileptiform discharges.

    Suzuki M, Jin K, Kitazawa Y, et al.

    Epilepsy & behavior : E&B 2020; (112()):107468 doi:10.1016/j.yebeh.2020.107468.

    PMID: 33181891
  28. 28

    Epilepsy with auditory features: Contribution of known genes in 112 patients.

    Bisulli F, Rinaldi C, Pippucci T, et al.

    Seizure 2021; (85()):115-118 doi:10.1016/j.seizure.2020.12.015.

    PMID: 33453592
  29. 29

    Resistant Temporal Lobe Epilepsy: Initial Steps into a Bigger Epilepsy Surgery Program.

    Mehrotra A, Singh S, Kanjilal S, et al.

    Journal of neurosciences in rural practice 2021; (12(1)):193-196 doi:10.1055/s-0040-1716796.

    PMID: 33531782
  30. 30

    Felt stigma in seizure-free persons with epilepsy: Associated factors and its impact on health-related quality of life.

    Lee SA,

    Epilepsy & behavior : E&B 2021; (122()):108186 doi:10.1016/j.yebeh.2021.108186.

    PMID: 34252827
  31. 31

    SUDEP risk and autonomic dysfunction in genetic epilepsies.

    Sahly AN, Shevell M, Sadleir LG, Myers KA

    Autonomic neuroscience : basic & clinical 2022; (237()):102907 doi:10.1016/j.autneu.2021.102907.

    PMID: 34773737
  32. 32

    Clinical Features, Immunotherapy, and Outcomes of Anti-Leucine-Rich Glioma-Inactivated-1 Encephalitis.

    Huang X, Fan C, Gao L, et al.

    The Journal of neuropsychiatry and clinical neurosciences 2022; (34(2)):141-148 doi:10.1176/appi.neuropsych.20120303.

    PMID: 34794327
  33. 33

    Sudden unexpected death in epilepsy.

    Friedman D

    Current opinion in neurology 2022; (35(2)):181-188 doi:10.1097/WCO.0000000000001034.

    PMID: 35102124
  34. 34

    Molecular typing of familial temporal lobe epilepsy.

    Liu C, Qiao XZ, Wei ZH, et al.

    World journal of psychiatry 2022; (12(1)):98-107 doi:10.5498/wjp.v12.i1.98.

    PMID: 35111581
  35. 35

    Epilepsy With Auditory Features: From Etiology to Treatment.

    Furia A, Licchetta L, Muccioli L, et al.

    Frontiers in neurology 2021; (12()):807939 doi:10.3389/fneur.2021.807939.

    PMID: 35153984
  36. 36

    Ictal aphasia in LGI1-related autosomal dominant epilepsy with auditory features.

    Moloney PB, McHugh J, O'Byrne J, et al.

    Practical neurology 2022; (22(4)):317-320 doi:10.1136/practneurol-2022-003366.

    PMID: 35354661
  37. 37

    DEPDC5-related epilepsy: A comprehensive review.

    Samanta D

    Epilepsy & behavior : E&B 2022; (130()):108678 doi:10.1016/j.yebeh.2022.108678.

    PMID: 35429726
  38. 38

    Discussion of the Brazilian neurologists about sudden unexpected death in epilepsy.

    Mosini A, Abdalla IG, Calió ML, et al.

    Revista da Associacao Medica Brasileira (1992) 2022; (68(5)):675-679 doi:10.1590/1806-9282.20220063.

    PMID: 35584495
  39. 39

    Current Management of Generalized Convulsive Status Epilepticus in Children.

    Aulická Š

    Children (Basel, Switzerland) 2022; (9(10)) doi:10.3390/children9101586.

    PMID: 36291522
  40. 40

    Localizing and lateralizing value of auditory phenomena in seizures.

    Cossette-Roberge H, Li J, Citherlet D, Nguyen DK

    Epilepsy & behavior : E&B 2023; (145()):109327 doi:10.1016/j.yebeh.2023.109327.

    PMID: 37422934
  41. 41

    Sudden Unexpected Death in Epilepsy and Respiratory Defects in a Mouse Model of DEPDC5-Related Epilepsy.

    Kao HY, Yao Y, Yang T, et al.

    Annals of neurology 2023; (94(5)):812-824 doi:10.1002/ana.26773.

    PMID: 37606181
  42. 42

    Nonconvulsive Status Epilepticus With Generalized Spike-and-Wave Discharges: Pathophysiological and Nosological Considerations.

    Wolf MC, Butner KS, Brinkley EB, et al.

    Cureus 2023; (15(10)):e47401 doi:10.7759/cureus.47401.

    PMID: 37869047
  43. 43

    Current challenges in focal epilepsy treatment: An Italian Delphi consensus.

    Di Gennaro G, Lattanzi S, Mecarelli O, et al.

    Epilepsy & behavior : E&B 2024; (155()):109796 doi:10.1016/j.yebeh.2024.109796.

    PMID: 38643659
  44. 44

    A de novo pathogenic variant in MICAL-1 causes epilepsy with auditory features.

    Bonanni P, Giorda R, Michelucci R, et al.

    Epilepsia open 2024; (9(3)):1083-1087 doi:10.1002/epi4.12937.

    PMID: 38654463
  45. 45

    Ictal Cotard delusion as a manifestation of nonconvulsive status epilepticus: A case report and commentary.

    Crespo Pimentel B, Kuchukhidze G, Heyduk M, et al.

    Epileptic disorders : international epilepsy journal with videotape 2024; (26(3)):375-381 doi:10.1002/epd2.20221.

    PMID: 38686977
  46. 46

    Clinical characteristics and surgical outcomes of epilepsy associated with temporal encephalocele: A systematic review.

    Zhou DJ, Woodson-Smith S, Emmert BE, et al.

    Epilepsy & behavior : E&B 2024; (158()):109928 doi:10.1016/j.yebeh.2024.109928.

    PMID: 38959747
  47. 47

    Clinical Features and Electroencephalogram Analysis of Brain Network Functional Connectivity in Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis.

    Guo X, Shi H, Sun Y, et al.

    Journal of inflammation research 2024; (17()):7881-7891 doi:10.2147/JIR.S485190.

    PMID: 39494201
  48. 48

    Seizure freedom and reducing the risk of sudden unexpected death in patients with focal epilepsy treated with cenobamate or other antiseizure medications.

    Sperling MR, Rosenfeld WE, Watson J, Klein P

    Epilepsia 2025; (66 Suppl 1()):4-14 doi:10.1111/epi.18307.

    PMID: 40105710
  49. 49

    Identification of autosomal dominant lateral temporal epilepsy caused by a novel mutation in RELN in China: a case report.

    Chen Y, Zhu Y, Zhong W, et al.

    Acta epileptologica 2024; (6(1)):31 doi:10.1186/s42494-024-00179-y.

    PMID: 40217319
  50. 50

    Evolution of epilepsy comorbidities in seizure free patients: Is no seizure a synonym of no epilepsy?

    Lagarde S, Bartolomei F

    Revue neurologique 2025; (181(5)):456-470 doi:10.1016/j.neurol.2025.04.004.

    PMID: 40246676
  51. 51

    Long-Term Adherence to a Subcutaneous Two-Channel EEG System in Patients With Focal Epilepsy.

    Zabler N, Novitskaya Y, Sprünken R, et al.

    Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society 2026; (43(2)):150-156 doi:10.1097/WNP.0000000000001169.

    PMID: 40391995
  52. 52

    Biallelic LGI1 and ADAM23 variants cause hippocampal epileptic encephalopathy via the LGI1-ADAM22/23 pathway.

    Hirano Y, Miyazaki Y, Ishikawa D, et al.

    Brain : a journal of neurology 2025; (148(10)):3514-3522 doi:10.1093/brain/awaf202.

    PMID: 40455867
  53. 53

    Whole Exome Sequencing Identifies Novel Homozygous LGI1 Variant Mimicking ADAM22-Related Pathologies in a Moroccan Family.

    El Mouhi H, Elmakhzen B, Bouyahyaoui A, et al.

    BMJ neurology open 2025; (7(2)):e001267 doi:10.1136/bmjno-2025-001267.

    PMID: 41000458
  54. 54

    Anti-LGI1 encephalitis: clinical presentation, imaging features, and prognostic analysis.

    Chen X, Liu Q, Wang X, et al.

    Frontiers in neurology 2025; (16()):1703647 doi:10.3389/fneur.2025.1703647.

    PMID: 41473232
  55. 55

    Ictal semiology in lateral temporal epilepsy: A systematic review and meta-analysis.

    Doerrfuss JI, Zimmermann G, Holtkamp M

    Epileptic disorders : international epilepsy journal with videotape 2026; (28(3)):678-689 doi:10.1002/epd2.70189.

    PMID: 41626773
  56. 56

    Translational Research Symposium: Current State of SUDEP Research.

    Ryan JM, Donner EJ, Zulfiqar-Ali Q, et al.

    Epilepsy currents 2026; 15357597261418785 doi:10.1177/15357597261418785.

    PMID: 41773238